Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesSubchondral bone marrow lesions are highly associated with, and predict subchondral bone attrition longitudinally: the MOST study
Osteoarthritis and Cartilage , 09/18/09
Roemer FW et al. – Prevalent and incident SBA is strongly associated with subchondral BMLs in the same subregion
Methods- Subjects with available baseline and 30-months follow-up MRI were included
- Subchondral BMLs and SBA were scored semiquantitatively from 0 to 3 in 10 tibiofemoral subregions
- 1025 knees were included
- 8.9% of the analyzed knee subregions showed SBA present at baseline and 9.2% of subregions exhibited prevalent subchondral BMLs
- The adjusted OR for prevalent SBA for subregions with prevalent BMLs was 18.8
- A larger BML size was directly associated with an increased risk of prevalent SBA
- 195 (2.2%) subregions exhibited incident SBA at follow-up
- The adjusted OR for incident SBA was 5.3 when compared to subregions without BMLs as the reference
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Article Search
Sponsor